DekaBank Deutsche Girozentrale’s Axsome Therapeutics AXSM Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$2.58M	–	1136
2025 Q4	$2.58M	Hold	30,000	–	–	﹤0.01%	716
2025 Q3	$3.49M	Hold	30,000	–	–	0.01%	646
2025 Q2	$3.08M	Hold	30,000	–	–	0.01%	666
2025 Q1	$3.52M	Hold	30,000	–	–	0.01%	629
2024 Q4	$2.18M	Hold	30,000	–	–	﹤0.01%	725
2024 Q3	$2.67M	Hold	30,000	–	–	﹤0.01%	707
2024 Q2	$2.38M	Hold	30,000	–	–	﹤0.01%	730
2024 Q1	$2.53M	Hold	30,000	–	–	﹤0.01%	713
2023 Q4	$2.36M	Hold	30,000	–	–	﹤0.01%	744
2023 Q3	$2.17M	Hold	30,000	–	–	0.01%	720
2023 Q2	$2.13M	Hold	30,000	–	–	﹤0.01%	737
2023 Q1	$1.79M	Hold	30,000	–	–	﹤0.01%	739
2022 Q4	$2.26M	Hold	30,000	–	–	0.01%	698
2022 Q3	$1.3M	Sell	30,000 -10,000	-25%	-$500K	﹤0.01%	809
2022 Q2	$1.43M	Buy	40,000 +25,650	+179%	+$811K	﹤0.01%	795
2022 Q1	$574K	Buy	14,350 +1,300	+10%	+$40.3K	﹤0.01%	1036
2021 Q4	$472K	Buy	13,050 +400	+3%	+$14.7K	﹤0.01%	1112
2021 Q3	$429K	Hold	12,650	–	–	﹤0.01%	1085
2021 Q2	$867K	Hold	12,650	–	–	﹤0.01%	948
2021 Q1	$698K	Hold	12,650	–	–	﹤0.01%	972
2020 Q4	$1.03M	Sell	12,650 -650	-5%	-$48.6K	﹤0.01%	863
2020 Q3	$947K	Buy	+13,300	New	+$1.04M	﹤0.01%	768

Other funds holding AXSM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AXSM Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Axsome Therapeutics (AXSM) in Q1 2026, closing a stake of 30,000 shares — an estimated $2.58M sold.

DekaBank Deutsche Girozentrale first reported a position in AXSM in Q3 2020 and held it in 22 quarters. The position peaked at $3.52M in Q1 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Axsome Therapeutics position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 30,000 Axsome Therapeutics shares in Q1 2026, an estimated $2.58M.
DekaBank Deutsche Girozentrale first reported a position in Axsome Therapeutics in Q3 2020 and held it in 22 quarters.
DekaBank Deutsche Girozentrale's Axsome Therapeutics position peaked at $3.52M in Q1 2025.
409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.